Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.20.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.20.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.20.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.110NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.110NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.110NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.86.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.86.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.86.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GN.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GN.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.8.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.8.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.8.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HB.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HB.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.10.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.10.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.89NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.89NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.89NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HR.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HP.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HP.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HP.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GW.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GW.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCF.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCF.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCF.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.34NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used